Home Ingredients Benexia® (Chia Seed, Salvia hispanica)
Cardiovascular

Benexia® (Chia Seed, Salvia hispanica)

Salvia hispanica
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Benexia® is a chia (Salvia hispanica) seed ingredient, available as seeds, oil and powder. Chia is a plant source of the omega-3 fatty acid ALA and provides fiber and protein. No trial of Benexia itself is cited here; the evidence comes from generic chia and another chia brand. A pooled analysis of 8 small trials found lower blood pressure and a slightly smaller waist, with no change in weight or BMI, though an earlier review rated all chia evidence low or very low certainty. Daily chia raised blood ALA in trials, but a 12-week trial in overweight adults found no change in weight, blood pressure or blood fats versus placebo. Small single-meal tests found a lower after-meal blood sugar rise and lower appetite ratings.

Studied Dose Trials cited here used 25 g/day of milled chia for 7 weeks and 50 g/day for 12 weeks; single-meal tests used 7 to 25 g.
Active Compound Chia seed (Salvia hispanica), rich in alpha-linolenic acid (ALA) omega-3, dietary fiber (including a gel-forming soluble fraction), and protein.

Benefits

Blood pressure and waist size

A pooled analysis of 8 small randomized trials (372 adults) of generic chia seed found lower systolic (about 5.6 mmHg) and diastolic (about 7.5 mmHg) blood pressure and a waist about 1.5 cm smaller, while weight and BMI did not change. An earlier review of 12 trials rated all chia evidence low or very low certainty, and in a 12-week trial (50 g/day, 76 overweight adults) blood pressure did not differ from placebo.

Supported by Trial 1

Omega-3 intake

Chia is a plant source of the omega-3 fatty acid ALA. Daily chia (25 to 50 g) raised plasma ALA in trials, and EPA rose about 30% in 10 postmenopausal women, but in a 12-week trial in 76 overweight adults, EPA, DHA and inflammation markers did not differ from placebo.

Supported by Trial 1

After-meal blood sugar and fullness

Chia's soluble fiber forms a thick gel in water. In two small single-meal tests in healthy adults (11 and 15 people), 7 to 25 g of Salba chia (another brand) baked into white bread or added to a glucose drink lowered the post-meal blood sugar rise, and appetite ratings were lower than after plain bread or flax.

Supported by Trial 1

Mechanism of action

1

Soluble fiber gel

Chia fiber absorbs many times its weight in water, forming a gel that may slow digestion and add to fullness.

2

ALA omega-3

Chia's alpha-linolenic acid is a plant omega-3. Eating chia raises plasma ALA, but conversion to the longer-chain omega-3s EPA and DHA appears limited, and a 12-week trial found no change in blood lipids or inflammation markers versus placebo.

Clinical trials

1
Chia Seed and Cardiometabolic Health: Meta-Analysis
PubMed

Systematic review and meta-analysis of randomized trials of chia seed on blood pressure and body composition. (Saadh et al. 2025, Clinical Therapeutics)

372 adults across 8 randomized trials.

Pooling 8 RCTs (372 adults) of generic chia, systolic blood pressure fell by 5.61 mmHg and diastolic by 7.49 mmHg, and waist circumference dropped 1.46 cm, while weight and BMI did not change significantly. The abstract gives no heterogeneity statistics or certainty grading, and the authors call for larger trials.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated as a food.
Eat with adequate fluid; dry chia can swell and cause choking or blockage.
Increase fiber intake gradually to avoid gas or bloating.

Important Drug interactions

Blood pressure medication: chia may add to its effect; monitor. Anticoagulants: any interaction is theoretical; check with a clinician.
May affect blood sugar; monitor if diabetic.
Take medications separately from large fiber doses.

More Cardiovascular Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids are polyunsaturated fats. EPA and DHA come from fish, krill and algae…
Cardiovascular
CoEnzyme Q10
Coenzyme Q10 (CoQ10) is a fat-soluble compound the body makes for itself. It carries elect…
Cardiovascular
Beetroot
Beetroot is a vegetable rich in dietary nitrate, which the body converts into nitric oxide…
Cardiovascular
Potassium
Potassium is the main mineral inside the body's cells and an essential nutrient for the el…

Explore Other Ingredients

Metabolic Health
Berberine
Berberine is a yellow compound from plants such as barberry, goldenseal and Chinese goldth…
Metabolic Health
GlucoVantage® (Dihydroberberine)
GlucoVantage® is NNB Nutrition's branded dihydroberberine (DHB), a reduced form of berberi…
Metabolic Health
Inositol (Myo-Inositol)
Inositol is a sugar-like compound that the body makes from glucose and that takes part in…

Frequently asked questions about Benexia® (Chia Seed, Salvia hispanica)

What is Benexia?

Benexia® is a chia (Salvia hispanica) seed ingredient, available as seeds, oil and powder. Chia is a plant source of the omega-3 fatty acid ALA and provides fiber and protein. No trial of Benexia itself is cited here; the evidence comes from generic chia and another chia brand.

What is Benexia used for?

Benexia is researched primarily for Cardiovascular. A pooled analysis of 8 small randomized trials (372 adults) of generic chia seed found lower systolic (about 5.6 mmHg) and diastolic (about 7.5 mmHg) blood pressure and a waist about 1.5 cm smaller, while weight and BMI did not change.

What is the recommended dosage of Benexia?

The clinically studied dose is Trials cited here used 25 g/day of milled chia for 7 weeks and 50 g/day for 12 weeks; single-meal tests used 7 to 25 g. Always follow the product label and check with a healthcare provider for personal advice.

Is Benexia safe, and does it have side effects?

Side effects and cautions reported for Benexia include: Generally well-tolerated as a food. Eat with adequate fluid; dry chia can swell and cause choking or blockage. It may also interact with some medications. Benexia is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Benexia interact with any medications?

Possible interactions include: Blood pressure medication: chia may add to its effect; monitor. Anticoagulants: any interaction is theoretical; check with a clinician. May affect blood sugar; monitor if diabetic. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Benexia?

NutraSmarts rates the evidence for Benexia as Limited (2 out of 5). It is backed by 1 study summary and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Saadh MJ, Abosaoda MK, Baldaniya L, Kalia R, Arya R, Mishra S, Chauhan AS, Kumar A, Alizadeh M. The Effects of Chia Seed (Salvia hispanica L.) Consumption on Blood Pressure and Body Composition in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Ther. 2025;47(2):168-175. doi: 10.1016/j.clinthera.2024.11.012.PubMedUsed to support: Meta-analysis of 8 randomized trials (372 adults) of generic chia seed: significant reductions in systolic (-5.61 mmHg) and diastolic (-7.49 mmHg) blood pressure and a modest fall in waist circumference (-1.46 cm), with no significant effect on body weight or BMI. This is generic-chia evidence and is not specific to Benexia.
  2. Jin F, Nieman DC, Sha W, Xie G, Qiu Y, Jia W. Supplementation of milled chia seeds increases plasma ALA and EPA in postmenopausal women. Plant Foods Hum Nutr. 2012;67(2):105-10. doi: 10.1007/s11130-012-0286-0.PubMedUsed to support: 7-week study in 10 postmenopausal women taking 25 g/day milled chia: plasma ALA rose 138% above baseline and EPA 30%, with no significant change in DPA and a slight fall in DHA.
  3. Nieman DC, Cayea EJ, Austin MD, Henson DA, McAnulty SR, Jin F. Chia seed does not promote weight loss or alter disease risk factors in overweight adults. Nutr Res. 2009;29(6):414-8. doi: 10.1016/j.nutres.2009.05.011.PubMedUsed to support: Single-blind 12-week placebo-controlled trial in 76 overweight/obese adults taking 50 g/day chia: plasma ALA rose 24.4% versus a 2.8% fall with placebo, but EPA, DHA, body mass and composition, inflammation, oxidative stress, blood pressure and lipoproteins did not differ from placebo.
  4. Vuksan V, Jenkins AL, Dias AG, Lee AS, Jovanovski E, Rogovik AL, Hanna A. Reduction in postprandial glucose excursion and prolongation of satiety: possible explanation of the long-term effects of whole grain Salba (Salvia Hispanica L.). Eur J Clin Nutr. 2010;64(4):436-8. doi: 10.1038/ejcn.2009.159.PubMedUsed to support: Acute controlled study in 11 healthy adults: 7, 15 or 24 g of Salba chia (a different chia brand, not Benexia) baked into white bread lowered post-meal blood glucose with dose, and appetite ratings were lower than with control bread at several time points up to 120 minutes.
  5. Vuksan V, Choleva L, Jovanovski E, Jenkins AL, Au-Yeung F, Dias AG, Ho HV, Zurbau A, Duvnjak L. Comparison of flax (Linum usitatissimum) and Salba-chia (Salvia hispanica L.) seeds on postprandial glycemia and satiety in healthy individuals: a randomized, controlled, crossover study. Eur J Clin Nutr. 2017;71(2):234-238. doi: 10.1038/ejcn.2016.148.PubMedUsed to support: Randomized crossover study in 15 healthy adults: 25 g ground Salba-chia (not Benexia) taken with a 50 g glucose drink lowered 2-hour blood glucose area under the curve versus glucose alone, and lowered appetite ratings compared with flax.
  6. Teoh SL, Lai NM, Vanichkulpitak P, Vuksan V, Ho H, Chaiyakunapruk N. Clinical evidence on dietary supplementation with chia seed (Salvia hispanica L.): a systematic review and meta-analysis. Nutr Rev. 2018;76(4):219-242. doi: 10.1093/nutrit/nux071.PubMedUsed to support: Systematic review and meta-analysis of 12 randomized trials of chia seed: pooled results showed no significant differences except, in higher-dose subgroups, lower post-meal blood glucose, lower HDL cholesterol (-0.10 mmol/L) and lower diastolic blood pressure (-7.14 mmHg). GRADE certainty of all evidence was low or very low, and all trials used only surrogate outcomes.